Neratinib is a quinoline compound with a cyano group, a 3-chloro-4-(2-pyridylmethoxy)anilino group, and other substituents. It functions as an antineoplastic agent and a tyrosine kinase inhibitor.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 698387-09-6
Neratinib maleate
pharmaceutical raw material
Pyrotinib
pharmaceutical raw material
Shr-1258 dimaleate
pharmaceutical raw material
Xl-228
pharmaceutical raw material
Wz-4002
pharmaceutical raw material
Repotrectinib
pharmaceutical raw material
Selitrectinib
pharmaceutical raw material
Fusidic acid
pharmaceutical raw material
(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
JWNPDZNEKVCWMY-VQHVLOKHSA-N
CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C